Fonnet et al found that in glioblastoma tumor samples occurrence of IDH1 R132H mutation reduced this capacity to produce NADPH by 38% and furthermore mutated IDH1 consumes rather than produces NADPH. The gene discussed is IDH1; the disease is neoplasm.